Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 15Gastrointestinal 9Tumor-Agnostic 4Genitourinary 4Head & Neck 3Gynecologic 3Thoracic 1Lymphoid 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neoplasms 4

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Decision Support Techniques × Tumor-Agnostic × Clear all
NCT06191679 2025-01-06

DECIDES B+

Children's Hospital of Philadelphia

Phase NA Completed
117 enrolled 17 charts
Tumor-Agnostic

Neoplasms

NCT03592433 2019-05-01

I Can PIC

Washington University School of Medicine

Phase NA Completed
263 enrolled
Tumor-Agnostic

Neoplasms

NCT03244202 2018-04-17

Evaluation of a Decision Aid for Incidental Genomic Findings

Unity Health Toronto

Phase NA Completed
133 enrolled
Tumor-Agnostic

Neoplasms

NCT01964222 2015-12-07

Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation

Washington University School of Medicine

Phase NA Completed
201 enrolled 12 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡